Industry: Pharmaceuticals, Biotechnology
Human BioSystems (OTC-BB:HBSC) was founded in February 1998 after more than ten years of research. We believe that our proposed technology represents a breakthrough in the storage and preservation of living biological materials that promises to reduce the waste and added cost factors of current technologies, while simultaneously increasing the worldwide availability of precious living biological materials needed to save human lives. HBS has two issued patents (with others pending) for technologies that preserve platelets (a blood component used by chemotherapy, trauma, and other patients to stop bleeding) and organs such as the kidney, heart, liver, and lung. These technologies are being developed for ( www.humanbiosystems.com )
Human BioSystems
1127 Harker Avenue
Palo Alto, California 94301
USA
Tel: (650) 323-0943